Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.14%
1,102.18
+1.57
+0.14%
—1,100.611,106.151,114.281,098.89——
SIXC
Communications
SIXC
Communications
SIXC
+0.64%
616.24
+3.94
+0.64%
—612.30612.30616.40612.30——
SIXE
Energy
SIXE
Energy
SIXE
+1.21%
1,189.72
+14.26
+1.21%
—1,175.461,182.971,193.951,182.97——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.20%
1,725.69
-3.43
-0.20%
—1,729.121,731.371,754.071,718.58——
SIXM
Financials
SIXM
Financials
SIXM
-0.17%
643.62
-1.11
-0.17%
—644.73645.31649.16642.15——
SIXR
Staples
SIXR
Staples
SIXR
+0.33%
829.79
+2.70
+0.33%
—827.09828.05833.90827.27——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.66%
213.40
-1.42
-0.66%
—214.82214.82216.61212.62——
SIXT
Technology
SIXT
Technology
SIXT
+2.27%
3,185.92
+70.75
+2.27%
—3,115.173,142.773,186.203,133.07——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.16%
908.94
-1.49
-0.16%
—910.43915.18923.94906.03——
SIXV
Health care
SIXV
Health care
SIXV
+0.30%
1,478.96
+4.46
+0.30%
—1,474.501,480.841,491.461,475.55——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.02%
2,405.36
-0.51
-0.02%
—2,405.872,415.572,420.792,398.99——
DRUG:NASDAQ
Bright Minds Biosciences Inc
$90.15
+3.12%
(+2.73) 1D
$90.15
0.00% (0.00)
After hours
Closed: Apr 22, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DRUG...
Open
$87.38
High
$90.15
Low
$87.00
Mkt. cap
1.20B
Avg. vol.
171.09K
Volume
0.00
52-wk high
$123.75
52-wk low
$23.18
Beta
-5.26
Shares outstanding
9.79M
No. of employees
26
News stories
From sources across the web
Cổng thông tin điện tử Tỉnh Sơn La
Cổng thông tin điện tử Tỉnh Sơn La
·
3 hours ago
Bright Minds (DRUG) Year-Ahead Outlook | Q4 2025: Earnings Report - Surprise Score
Profile
Bright Minds Biosciences is an American pharmaceutical company which is developing serotonin 5-HT₂ receptor agonists for potential medical use. It has a particular focus on serotonin 5-HT2C receptor agonists, for instance to treat rare epilepsies and other conditions. Another area of focus for the company is serotonergic psychedelics and non-hallucinogenic psychoplastogens. The company was co-founded by Ian McDonald and Gideon Shapiro. The lead scientist at Bright Minds Biosciences was previously Alan Kozikowski. Bright Mind Biosciences was founded in 2017 and its headquarters are in New York City, New York. Wikipedia
About Bright Minds Biosciences Inc
CEO-
Employees26
Founded2017
Headquarters-
SectorBiotechnology
Websitebrightmindsbio.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.56M
2.69M
4.78M
5.66M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
676.16K
591.94K
749.11K
1.08M
Operating expense
3.24M
3.03M
5.79M
6.74M
Total operating expenses
3.24M
3.03M
5.79M
6.74M
Operating income
-3.24M
-3.03M
-5.79M
-6.74M
Other non operating income
-112.84K
-12.52K
-123.93K
-154.22K
EBT including unusual items
-2.95M
-5.24M
-4.09M
-7.57M
EBT excluding unusual items
-2.95M
-5.24M
-4.09M
-7.57M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-257.87K
257.87K
-
Net income
-2.95M
-5.24M
-4.09M
-7.57M
Net profit margin
-
-
-
-
Earnings per share
-0.42
-0.74
-0.58
-0.97
Interest and investment income
509.38K
476.23K
529.54K
818.26K
Interest expense
-
-
-7.30K
-6.58K
Net interest expenses
509.38K
476.23K
522.24K
811.69K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer